一名患有新型冠状病毒肺炎的33岁男性出现亚急性甲状腺炎：一例罕见病例报告及文献综述。
A 33-year-old man with COVID-19 presented with subacute thyroiditis: A rare case report and literature review.
作者信息
Davoodi L, Oladi Z, Jafarpour H, Zakariaei Z, Soleymani E, Razavi A
机构信息
Department of Infectious Diseases, School of Medicine, Antimicrobial Resistance Research Centre, Communicable Diseases Research Institutes, Ghaem Shahr Razi Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
Department of Internal Medicine, School of Medicine, Ghaem Shahr Razi Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
出版信息
New Microbes New Infect. 2021 May;41:100871. doi: 10.1016/j.nmni.2021.100871. Epub 2021 Mar 22.
We report the first case of the novel coronavirus disease 2019 (COVID-19) presenting with subacute thyroiditis in Ghaemshar, Mazandaran Province, Iran. In our patient, with the initiation of corticosteroid therapy, the symptoms of subacute thyroiditis gradually disappeared with a slow increase in thyroid-stimulating hormone (TSH) and the gradual elimination of thyrotoxicosis. This case shows that decreased TSH and persistent thyrotoxicosis may make the patient's condition worse. Managing this complication can take several weeks and can be complicated.
我们报告了伊朗马赞德兰省加姆沙尔首例新型冠状病毒肺炎（COVID-19）合并亚急性甲状腺炎的病例。在我们的患者中，随着皮质类固醇治疗的开始，亚急性甲状腺炎的症状逐渐消失，促甲状腺激素（TSH）缓慢升高，甲状腺毒症逐渐消除。该病例表明，TSH降低和持续性甲状腺毒症可能会使患者病情恶化。处理这种并发症可能需要数周时间，且可能较为复杂。
Zotero 插件